Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants

BACKGROUND: The majority of coeliac disease (CD) patients are not being properly diagnosed and therefore remain untreated, leading to a greater risk of developing CD-associated complications. The major genetic risk heterodimer, HLA-DQ2 and DQ8, is already used clinically to help exclude disease. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanos, Jihane, Rosén, Anna, Kumar, Vinod, Trynka, Gosia, Franke, Lude, Szperl, Agata, Gutierrez-Achury, Javier, van Diemen, Cleo C, Kanninga, Roan, Jankipersadsing, Soesma A, Steck, Andrea, Eisenbarth, Georges, van Heel, David A, Cukrowska, Bozena, Bruno, Valentina, Mazzilli, Maria Cristina, Núñez, Concepcion, Bilbao, Jose Ramon, Mearin, M Luisa, Barisani, Donatella, Rewers, Marian, Norris, Jill M, Ivarsson, Anneli, Boezen, H Marieke, Liu, Edwin, Wijmenga, Cisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Coeliac Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933173/
https://www.ncbi.nlm.nih.gov/pubmed/23704318
http://dx.doi.org/10.1136/gutjnl-2012-304110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933173/
https://www.ncbi.nlm.nih.gov/pubmed/23704318
http://dx.doi.org/10.1136/gutjnl-2012-304110

Ejemplares similares